NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

到2021年可注射藥物市場的詳細分析

Injectable Drugs DeepDive 2021

出版商 Greystone Research Associates 商品編碼 991779
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
到2021年可注射藥物市場的詳細分析 Injectable Drugs DeepDive 2021
出版日期: 2021年01月31日內容資訊: 英文
簡介

本報告調查了注射劑市場,並提供了對產品和公司的全面評估和分析,包括關鍵市場領域,市場動態,潛在產品機會,領先公司及其業務戰略,競爭狀況以及經濟,技術和法規因素。

調查內容

  • 注射情況變化的動態是什麼?
  • 提供FDA批准的注射劑評估,以評估關鍵細分市場,市場動態和潛在的產品機會
  • 主要的注射設備公司是哪些?什麼是商業策略?
  • 介紹20種藥物類別中註射劑的競爭情況
  • 評估ANDA/NDA/BLA應用策略對進入者增長前景的重要性
  • 評估排名前24位的注射劑供應商的市場佔有率和產品位置
  • 評估經濟,技術和監管因素的影響

目錄

  • 注塑市場機會
  • 注塑市場領域
  • FDA批准的注射劑-治療藥物市場領域
  • 注射API-產品機會表
  • 注射用重組蛋白
  • 公司活動概述
目錄
Product Code: JDF746K

Making Sense of the Injectable Drug Landscape

This report is a comprehensive evaluation and analysis of the products and participants in this evolving segment of the therapeutic drug sector. It is designed to provide drug product decision makers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, disease segments, and commercial opportunities for injectables. These products are marketed and supplied by slightly less than one hundred companies. Competition among the various drug and therapeutic classes is uneven, with the top ten segments accounting for a disproportionate level of activity and revenue. Understanding the underlying factors affecting business performance is key to attaining financial targets. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

What You Will Learn:

  • What are the dynamics of the shifting landscape for injectable drugs?
  • Provides assessments of FDA-approved injectable drugs assesses key market segments, market dynamics and potential product opportunities
  • Who are the leading injection device companies, and what are their business strategies?
  • Presents the competitive picture injectables in two dozen drug classes
  • Evaluates the importance of ANDA/NDA/BLA filing strategies on participant growth prospects
  • Assesses the market presence and product position of the top twenty-four injectables suppliers
  • Evaluates the impact of economic, technology, and regulatory factors

Table of Contents

  • Injectables Market Opportunities
  • Injectable Drug Market Segment
  • FDA-Approved Injectable Drugs - Market Segment Therapeutics
  • Injectable Drug APIs - Product Opportunity Charts
  • Injectable Recombinant Proteins
  • Company Activity Summaries